{"id":154251,"date":"2021-01-20T01:13:19","date_gmt":"2021-01-20T06:13:19","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/genocea-to-participate-in-the-b-riley-securities-virtual-oncology-investor-conference\/"},"modified":"2024-08-18T11:43:00","modified_gmt":"2024-08-18T15:43:00","slug":"genocea-to-participate-in-the-b-riley-securities-virtual-oncology-investor-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/genocea-to-participate-in-the-b-riley-securities-virtual-oncology-investor-conference.php","title":{"rendered":"Genocea to Participate in the B. Riley Securities\u2019 Virtual Oncology Investor Conference"},"content":{"rendered":"<p><![CDATA[CAMBRIDGE, Mass., Jan.  19, 2021  (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will participate in a fireside chat at B. Riley Securities\u2019 Virtual Oncology Investor Conference on January 21, 2021 from 11:00 am \u2013 11:30 am Eastern Time. A live webcast of the fireside chat will be available on the Genocea website at http:\/\/ir.genocea.com. This event will also remain archived on the Genocea website for approximately 90 days.]]><\/p>\n<p>Go here to see the original:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2021\/01\/19\/2161080\/0\/en\/Genocea-to-Participate-in-the-B-Riley-Securities-Virtual-Oncology-Investor-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Genocea to Participate in the B. Riley Securities\u2019 Virtual Oncology Investor Conference\">Genocea to Participate in the B. Riley Securities\u2019 Virtual Oncology Investor Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Go here to see the original: Genocea to Participate in the B. Riley Securities\u2019 Virtual Oncology Investor Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/genocea-to-participate-in-the-b-riley-securities-virtual-oncology-investor-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-154251","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/154251"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=154251"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/154251\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=154251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=154251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=154251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}